Who
Carolyn R. Bertozzi
Director
Company insider
Files Form 4 as: Director, OmniAb; Director, Alnylam Pharmaceuticals; Director, Eli Lilly and.
In numbers
- Trades disclosed
- 35
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 20 Nov 2017
- Last trade
- 17 Jun 2026
- Last filed
- 18 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAbLife-science tools | SEC FORM 4 Code M | —20,000 | filing |
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 17 Jun 2026filed 18 Jun 2026 | OABI OmniAbLife-science tools | SEC FORM 4 Code M | —20,000 | filing |
| 1 Nov 2025filed 3 Nov 2025 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code M | —17,769 at $0.00 | filing |
| 1 Nov 2025filed 3 Nov 2025 | OABI OmniAbLife-science tools | SEC FORM 4 Code M | —17,769 | filing |
| 17 Jun 2025filed 18 Jun 2025 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 17 Jun 2025filed 18 Jun 2025 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 17 Jun 2025filed 18 Jun 2025 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 17 Jun 2025filed 18 Jun 2025 | OABI OmniAbLife-science tools | SEC FORM 4 Code M | —20,000 | filing |
| 8 May 2025filed 12 May 2025 | ALNY Alnylam Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,558 at $0.00 | filing |
| 8 May 2025filed 12 May 2025 | ALNY Alnylam PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —775 at $0.00 | filing |
| 1 Nov 2024filed 1 Nov 2024 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code M | —17,769 at $0.00 | filing |
| 1 Nov 2024filed 1 Nov 2024 | OABI OmniAbLife-science tools | SEC FORM 4 Code M | —17,769 | filing |
| 18 Jun 2024filed 21 Jun 2024 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 18 Jun 2024filed 21 Jun 2024 | OABI OmniAboption or derivative · Life-science tools | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.